Correlation Between Roche Holding and Santen Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Roche Holding and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roche Holding and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roche Holding Ltd and Santen Pharmaceutical Co, you can compare the effects of market volatilities on Roche Holding and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roche Holding with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roche Holding and Santen Pharmaceutical.
Diversification Opportunities for Roche Holding and Santen Pharmaceutical
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Roche and Santen is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Roche Holding Ltd and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and Roche Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roche Holding Ltd are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of Roche Holding i.e., Roche Holding and Santen Pharmaceutical go up and down completely randomly.
Pair Corralation between Roche Holding and Santen Pharmaceutical
Assuming the 90 days horizon Roche Holding Ltd is expected to generate 0.46 times more return on investment than Santen Pharmaceutical. However, Roche Holding Ltd is 2.17 times less risky than Santen Pharmaceutical. It trades about 0.06 of its potential returns per unit of risk. Santen Pharmaceutical Co is currently generating about 0.02 per unit of risk. If you would invest 3,289 in Roche Holding Ltd on September 2, 2024 and sell it today you would earn a total of 327.00 from holding Roche Holding Ltd or generate 9.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Roche Holding Ltd vs. Santen Pharmaceutical Co
Performance |
| Timeline |
| Roche Holding |
| Santen Pharmaceutical |
Roche Holding and Santen Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Roche Holding and Santen Pharmaceutical
The main advantage of trading using opposite Roche Holding and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roche Holding position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.| Roche Holding vs. Brainsway | Roche Holding vs. Venus Concept | Roche Holding vs. Tactile Systems Technology | Roche Holding vs. Icecure Medical |
| Santen Pharmaceutical vs. Sanofi ADR | Santen Pharmaceutical vs. Bristol Myers Squibb | Santen Pharmaceutical vs. AstraZeneca PLC ADR | Santen Pharmaceutical vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |